Clinical Trials Logo

Clinical Trial Summary

Objectives: To demonstrate the efficacy of care transition holistic intervention (Multilevel Guided Discharge Planning, MGDP) in reducing 30-day adverse outcomes among frail older patients with acute heart failure (AHF) discharged from Emergency Departments (EDs) and to validate the results of MGDP in real life.

Method: Investigators will select frail patients ≥70 years with primary diagnosis of AHF discharged from EDs. The intervention will consist of MGDP implementation: 1) checklist that includes clinical recommendations and resources activations; 2) scheduling of early visit with the specialist; 3) communication with primary care; 4) providing a written instruction sheet to patient or caregiver. Phase 1: matched-pair cluster randomized clinical trial. EDs were randomly allocated to intervention (n = 10) or control (n = 10) group. Investigators will compare the outcomes between intervention and control groups. Phase 2: a quasi-experimental study. The 20 EDs will carry out the intervention. Investigators will compare the outcomes between phase 1 and phase 2 of intervention group and between phase 1 and phase 2 of control group. The main outcome is a 30-day composite endpoint (ED revisit or hospital admission for AHF and cardiovascular death) after being discharged.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03696875
Study type Interventional
Source Hospital San Carlos, Madrid
Contact Francisco Javier Martín-Sánchez, MD, PhD.
Phone +34 91.330.37.50
Email fjjms@hotmail.com
Status Not yet recruiting
Phase N/A
Start date January 15, 2019
Completion date May 15, 2022

See also
  Status Clinical Trial Phase
Terminated NCT02151383 - Pharmacokinetics & Safety of Serelaxin on Top of Standard of Care Therapy in Pediatric Patients With Acute Heart Failure Phase 2
Completed NCT02135835 - A Study to Evaluate the Efficacy and Safety of Shenfu Zhusheye in Patients With Acute Heart Failure Phase 4
Completed NCT02122640 - Evaluation of Acute Cardiogenic Dyspnoea With Thorax Echography and Pro-BNP in the Emergency Department N/A
Completed NCT01193998 - Impact of Validated Diagnostic Prediction Model of Acute Heart Failure in the Emergency Department N/A
Not yet recruiting NCT01211886 - Utility of Brain Natriuretic Peptide (BNP) in Patients With Type IV Cardio-renal Syndrome Admitted to the Intensive Care Unit (ICU) N/A
Active, not recruiting NCT00512759 - Goal-directed Afterload Reduction in Acute Congestive Cardiac Decompensation Study Phase 4
Recruiting NCT03157219 - Manipal Heart Failure Registry (MHFR) N/A
Enrolling by invitation NCT02258984 - Can the Venus 1000 Help Clinicians Treat Patients With Severe Sepsis or Acute Heart Failure? The CVP Trial N/A
Completed NCT02141607 - Evolution of Molecular Biomarkers in Acute Heart Failure Induced by Shock
Completed NCT01870778 - Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF Phase 3
Not yet recruiting NCT03681379 - Pharmacokinetics of Levosimendan in Pediatric Intensive Care Units
Recruiting NCT03161158 - PURE-HF: Peripheral Ultrafiltration for the RElief From Congestion in Heart Failure N/A
Not yet recruiting NCT03683212 - Early and Comprehensive Care Bundle in Elderly for Acute Heart Failure: a Stepped Wedge Cluster Randomized Trial N/A
Recruiting NCT03110042 - HILO-HF Registry: High Versus Low SpO2 Oxygen Therapy in Patients With Acute Heart Failure N/A
Completed NCT02350114 - An Observational Study of the Functional Capacity of Heart Failure N/A
Recruiting NCT01704131 - Levosimendan Pharmacokinetics in Children N/A
Completed NCT00561483 - Sequential Cystatin C Levels and Renal Impairment in Acute Heart Failure N/A
Withdrawn NCT02299726 - Early Aldosterone Blockade in Acute Heart Failure: An Exploratory Safety Study Phase 2
Completed NCT01834833 - Consultation at 8 Days to Reduce Hospitalisations in Heart Failure Patient N/A
Completed NCT01614860 - Identification of Patient Phenotypes Associated With Elevated Aldosterone Levels N/A